Ex Vivo Treatment Response Prediction in Multiple Myeloma: Assay Formats, Clinical Correlation, and Future Directions.

Cancers (Basel) · 2026 · PMC12896484 · PMID 41681883

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

tended toward significanceno p-value reported

In terms of actual clinical correlation, when they compared combination screening data with in vivo clinical responses, patients classified as responders ( n = 9) tended toward significance of increased ex vivo sensitivity (median DSS of 51.8) versus patients achieving poor response, with a median DSS of 23.4 ( n = 4; minimal response (MR) = 1, stable disease (SD) = 1, progressive disease (PD) = 2).

also in 121 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.